Treatment cascades show 90-90-90 goal within reach for some – but Eastern Europe lags behind Africa
The pros and cons of PrEP: trial volunteers recount their experience of the ADAPT study
Cash compensation encourages uptake of circumcision, PMTCT services
Active invitation and tracing more likely to get men involved in couples HIV counselling and testing
Cash to stay in school doesn’t reduce HIV incidence in South African study – but school attendance protected young women against HIV
START trial provides definitive evidence of the benefits of early HIV treatment
Innovative approaches to linkage to care boost clinic visits, HIV treatment uptake in African study
Non-daily PrEP regimens provide extra options, but adherence is often better with daily dosing
Targets proliferate in HIV cure research
No HIV infections from partners with fully suppressed viral load during long-term follow up of landmark treatment as prevention trial
Young woman stays undetectable for twelve years off treatment after early HIV therapy
Presumptive treatment of TB in advanced HIV no better than giving ART and isoniazid
Access to screening and treatment are key issues for hepatitis B and C and HIV/viral hepatitis co-infection
Vancouver Consensus Statement calls for early access to treatment and PrEP worldwide
World Health Organization urges more HIV testing by non-medical staff, outside of clinical settings, targeted to those who need it the most
World Health Organization to recommend HIV treatment for all
Test and treat studies and African countries showing that 90-90-90 targets are achievable
